Back to top

Image: Shutterstock

Zacks.com featured highlights include: Halliburton Company, AmerisourceBergen, Cardinal Health, ABM Industries and Dillard's

Read MoreHide Full Article

For Immediate Release

Chicago, IL – March 25, 2020 – Stocks in this week’s article are Halliburton Company (HAL - Free Report) , AmerisourceBergen , Cardinal Health (CAH - Free Report) , ABM Industries (ABM - Free Report) and Dillard's (DDS - Free Report) .

5 Stocks Brokers Favor Amid Coronavirus Crisis

The coronavirus pandemic shook stock markets all around the globe, spooking investors in the process. Even though every nook and corner of the investing space is seen bearing the brunt of this health hazard, travel-focused stocks are one of the worst-hit with people unwilling to venture out, thereby shrinking travel demand and hurting revenues.

However, investors always look to make profits from their portfolios irrespective of the surrounding scenario. They are after all infusing their hard-earned money into the stock market. Therefore, in these trying times, it is best to design a well-diversified portfolio (including stocks from different spheres).

However, the task seems quite daunting as the market is chock-a-block with companies. Moreover, the complexities associated with the stock market make it even more difficult for individual investors to select outperformers for their portfolios in absence of proper guidance from “experts” in the field. These “experts” are brokers who are well-equipped with detailed knowledge on the space.

Brokers, irrespective of their types (sell-side, buy-side or independent), have at their disposal a deluge of information on a company’s profile and its prospects than individual investors. To enrich their database, they scan the minute details of the publicly available financial documents apart from attending company conference calls and other presentations. 

Estimate revisions by brokers serve as a key pointer regarding the price of a stock.  In fact, a rating upgrade generally leads to stock price appreciation. Similarly, the price of a stock may plummet following a rating downgrade.

Winning Strategy

The above write-up clearly suggests that by following broker actions, one can arrive at a gamut of lucrative stocks. Keeping this in mind, we designed a screen to shortlist stocks based on improving analyst recommendation and upward revisions of earnings estimates over the last four weeks.

Also, since the price/sales ratio is a strong complementary valuation metric in the presence of analyst information, it has been included. The price/sales ratio takes care of the company’s top line, making the strategy foolproof.

For the rest of this Screen of the Week article please visit Zacks.com at:https://www.zacks.com/stock/news/831768/5-stocks-that-brokers-favor-amid-coronavirus-crisis

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

 

 

 

            

Published in